HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-49 Cr | ₹-52 Cr | ₹-26 Cr | ₹42 Cr | ₹112 Cr |
What is the latest Cash Flow from Financing Activities ratio of HESTER BIOSCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-49 Cr |
| Mar2025 | ₹-52 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹112 Cr |
How is Cash Flow from Financing Activities of HESTER BIOSCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-49 Cr | Negative | |
| Mar2025 | ₹-52 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹42 Cr | -62.56 | |
| Mar2022 | ₹112 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,772.3 Cr | -4.3% | 5.9% | 21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -4.3% |
5.9% |
21.8% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses